Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Pruritus Therapeutics Market Expected To Grow In Terms Of Size?

In recent times, there has been a consistent increase in the market size of pruritus therapeutics. From $11.89 billion in 2024, it is set to expand to $12.38 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.1%. The historical period’s development can be related to an increase in pruritus cases, varied reasons and conditions, an escalating elderly population, and a focus on bettering patient life quality.

There is an anticipated strong surge in the pruritus therapeutics market over the next couple of years. The market is projected to expand to “$15.7 billion by 2029 with an impressive compound annual growth rate (CAGR) of 6.1%. This anticipated growth in the prognosis period can be linked to an improved understanding of pruritus pathophysiology, advancements in drug formulations and delivery, a shift toward personalized medicine, an escalation in dermatological R&D, enhanced awareness and diagnosis rates, and escalating interest in plant-based and herbal solutions. Key trends during the prognosis period will include the creation of itch-specific receptor agonists and antagonists, the increased market focus on personalized therapeutic strategies, the merging of technology in itch tracking and treatment, and partnerships for interdisciplinary research.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

Which Industry Forces Are Driving The Pruritus Therapeutics Market Forward?

An increase in the prevalence of skin-related disorders is projected to boost the pruritus therapeutics market’s expansion. Dermatological issues cover a spectrum from acne and eczema to skin cancer and fungal infections and can include conditions relating to skin, hair, nails, and mucous membranes. The specific cause of the itchiness frequently dictates the application of pruritus treatments for these skin diseases. Treatments include topical applications, emollients and moisturizers, medications that suppress the immune system, and medicines specifically for itching. For example, the American Cancer Society, a non-profit organization based in the US committed to eradicating cancer, anticipated 108,270 skin cancer cases in January 2024, a 3.2% rise from the 104,930 instances recorded in 2023. So, the escalating incidence of skin disorders is fuelling the pruritus therapeutics market’s growth.

What Is The Segment Breakdown Of The Pruritus Therapeutics Market?

The pruritus therapeutics market covered in this report is segmented –

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

How Are Global Trends Impacting The Development Of The Pruritus Therapeutics Market?

Leading firms in the pruritus therapeutics market are concentrating on the creation of targeted remedies for specific patient groups and rare conditions, such as a non-systemic ileal bile acid transport inhibitor. This personal approach to medicine aims to fill gaps in currently available treatments. This specific type of drug targets the absorption of bile acid in the gut without major impacts on the body’s systemic circulation, thus reducing potential side effects. For instance, in June 2023, Ipsen, a pharmaceutical company from France, was granted approval from the Food and Drug Administration (FDA), an agency of the US Department of Health and Human Services, for the use of Bylvay (odevixibat) to treat cholestatic pruritus in Alagille syndrome (ALGS) patients who are at least 12 months old. Bylvay, an IBATi taken once daily, demonstrates very little systemic exposure and is the first FDA approved treatment for cholestatic pruritus related to progressive familial intrahepatic cholestasis (PFIC) in the United States. The drug had already been approved for PFIC treatment in Europe and is now available by prescription for eligible ALGS patients in the US.

Which Firms Are Driving Innovation Within The Pruritus Therapeutics Market?

Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Pruritus Therapeutics Market?

North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model